Journals / Retina-Vitreus / 2009 / Cilt: 17 - Sayı: 2

Diyabetik vitreus kanamasının tedavisinde 25 gauge sütürsüz vitrektomi ve 20 gauge vitrektomi tekniklerinin karşılaştırılması

Comparison of 25 gauge sutureless and 20 gauge vitrectomy techniques for the management of diabetic vitreous hemorrhage

Pages
101–107
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further prospective randomized and controlled studies with larger series and with longer follow-up are warranted.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To compare anatomical and functional outcomes of 25 gauge sutureless pars plana vitrectomy (PPV) and 20 gauge PPV in eyes with diabetic vitreous hemorrhage (VH).
📊
Key Findings & Data:Materials and Methods: IIn this interventional case series 15 eyes (Group 1) underwent 20-gauge PPV, and 29 eyes (Group 2) underwent 25 gauge sutureless PPV with oblique sclerotomies due to diabetic VH.
💡
Conclusion & Impact:Further prospective randomized and controlled studies with larger series and with longer follow-up are warranted.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Oftalmolojik cerrahi işlemler · Karşılaştırmalı çalışma · Çevresel çökertme

Abstract

Purpose: To compare anatomical and functional outcomes of 25 gauge sutureless pars plana vitrectomy (PPV) and 20 gauge PPV in eyes with diabetic vitreous hemorrhage (VH). Materials and Methods: IIn this interventional case series 15 eyes (Group 1) underwent 20-gauge PPV, and 29 eyes (Group 2) underwent 25 gauge sutureless PPV with oblique sclerotomies due to diabetic VH. Eyes with a minimum follow-up of 6 months were evaluated. The main outcome measures were changes in visual acuity (VA), intraocular pressure (IOP), and rates of complications. Results: In all eyes PPV was performed without complication. The mean follow-up period was 14±9.14 months. Mean VA in Group 1 increased significantly at postoperative week 1 and thereafter, whereas it increased in Group 2 at postoperative month 1 and thereafter (p<0.05). Mean log- MAR change, mean IOP levels, and rates of complications did not differ significantly between the two groups during follow-up (p>0.05). Transient hypotony was detected in 3 eyes in Group 2 only (p>0.05). Revitrectomy was performed in 1 (6.66%) and 3 (10.34%) eyes due to postoperative rehemorrhage in the two groups, respectively (p>0.05). Conclusions: In this study 25 gauge sutureless pars plana vitrectomy with oblique sclerotomies and 20 gauge vitrectomy were similarly effective and safe in the treatment of diabetic VH. Further prospective randomized and controlled studies with larger series and with longer follow-up are warranted.

Özet

Amaç: Diyabetik vitreus kanaması olan gözlerde uygulanan 25 gauge sütürsüz pars plana vitrektomi (PPV) ve 20 gauge PPV ile elde edilen anatomik ve fonksiyonel sonuçları karşılaştırmak. Gereç ve Yöntemler: Bu girişimsel olgu serisinde, diyabetik vitreus kanaması nedeniyle 15 göze 20 gauge PPV (Grup 1), 29 göze ise oblik girişli sklerotomiler ile 25 gauge sütürsüz PPV (Grup 2) uygulandı. En az 6 ay takip edilen gözler incelendi. Başlıca incelenen parametreler görme keskinliğindeki (GK), göziçi basıncındaki (GİB) değişiklikler ve komplikasyon oranlarıydı. Bulgular: Tüm gözlerde PPV komplikasyonsuz tamamlandı. Ortalama takip süresi 14±9.14 aydı. Ortalama görme keskinliği, 1. Grupta postoperatif 1.haftada ve sonrasında anlamlı olarak artarken, 2. Grupta postoperatif 1.ayda ve sonrasında anlamlı olarak arttı (p 0.05). Geçici hipotoni, sadece 2. Grupta ve 3 gözde görüldü (p>0.05). Postoperatif tekrar hemoraji nedeniyle ikinci kez PPV, 1.Grupta 1 (%6.66) gözde, 2. Grupta ise 3 (%10.34) gözde uygulandı (p>0.05). Sonuç: Bu çalışmada, diyabetik vitreus kanamasının tedavisinde oblik girişli sklerotomilerle uygulanan 25 gauge sütürsüz PPV ve 20 gauge PPV benzer şekilde etkin ve güvenli bulunmuştur. Daha uzun takip süreli daha geniş serilerle yapılacak prospektif randomize kontrollü çalışmalara gerek vardır.

🔖

Cite This Article

ACAR, N., KAPRAN, Z., ALTAN, T., ÜNVER, Y. B., YURTTAŞER, S. (2009). Diyabetik vitreus kanamasının tedavisinde 25 gauge sütürsüz vitrektomi ve 20 gauge vitrektomi tekniklerinin karşılaştırılması. Retina-Vitreus, Cilt: 17 - Sayı: 2, 101–107. https://ajindex.com/articles/305169

References (14)

  1. Diabetic Retinopathy Vitrectomy Study Research Group.: Early vitrectomy for severe vitreous hemorrhage in diabetic vitrectomy: two-year results of a randomized trial, Diabetic Retinopathy Vitrectomy Study Report 2. Arch Ophthalmol. 1985;103:1644
  2. Thompson JT, de Bustros S, Michels RG, et al.: Results and prognostic factors in vitrectomy for diabetic vitreous hemorrhage. Arch Ophthalmol. 1987;105:191-5. Erratum in: Arch Ophthalmol. 1987;105:496
  3. Diabetic Retinopathy Vitrectomy Study Research Group.: Early vitrectomy for severe vitreous hemorrhage in diabetic vitrectomy: four-year results of a randomized trial, Diabetic Retinopathy Vitrectomy Study Report 5. Arch Ophthalmol. 1990;108:958
  4. Yorston D, Wickham L, Benson S, et al.: Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy. Br J Ophthalmol. 2008;92:365-368
  5. Faghihi H, Taheri A, Farahvash MS, et al.: Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: A Randomized, Clinical Trial. Retina. 2008;3
  6. Bahar I, Axer-Siegel R, Weinberger D.: Pars plana vitrectomy: comparison of three techniques for the treatment of diabetic vitreous hemorrhage. Ophthalmic Surg Lasers Imaging. 2006;37:364-369
  7. Mason JO 3rd, Colagross CT, Vail R.: Diabetic vitrectomy: risks, prognosis, future trends. Curr Opin Ophthalmol. 2006;17:281-285
  8. Kapran Z, Acar N.: Proliferatif diyabetik retinopati tedavisi. Ret- Vit. 2008;16:85-90
  9. Kağnıcı K B, Özdek Ş, Özdoğan S, ve ark.: İleri proliferatif diyabetik retinopatide vitreoretinal cerrahi sonrası görsel ve anatomik başarı sonuçlarımız. Ret-Vit. 2006;14:251-256
  10. Bardak Y, Tiğ Ş, Çekiç O ve ark.: Proliferatif diabetik retinopatide pars plana vitrektomi sonuçlarımız. Ret-Vit. 2006;14:275-280
  11. Fujii GY, De Juan E Jr, Humayun MS, et al.: A new 25 gauge instrument system for transconjunctival sutureless vitrectomy surgery. Ophthalmology 2002;109:1807-12; discussion 1813. Erratum in: Ophthalmology 2003;110:9
  12. Fujii GY, De Juan E Jr, Humayun MS, et al.: Initial experience using the transconjunctival sutureless vitrectomy system for vitreoretinal surgery. Ophthalmology. 2002;109:1814-1820
  13. Lakhanpal RR, Humayun MS, de Juan E Jr, et al.: Outcomes of 140 consecutive cases of 25 gauge transconjunctival surgery for posterior segment disease. Ophthalmology. 2005;112:817-824
  14. Ibarra MS, Hermel M, Prenner JL, et al.: Longer-term outcomes of transconjunctival sutu